Atomoxetine for amphetamine-type stimulant dependence during buprenorphine treatment: A randomized controlled trial. Schottenfeld RS, Chawarski MC, Sofuoglu M, Chooi WT, Zaharim NM, M Yasin MA, Ahmad I, Syed Jaapar SZ, Vicknasingam BK. Drug Alcoho…

mCPP: an undesired addition to the ecstasy market MG BossongTM BruntJP Van DijkSM RigterJ. HoekHMJ GoldschmidtRJM Niesink Journal of Psychopharmacology, Vol 24, Issue 9, pp. 1395 – 1401, doi.org/10.1177/0269881109102541 http://journals.s…

The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities. Faraone SV. Neurosci Biobehav Rev. 2018 Feb 8;87:255-270. doi: 10.1016/j.neubiorev…

Multifaceted empathy of healthy volunteers after single doses of MDMA: A pooled sample of placebo-controlled studies. Kuypers KP, Dolder PC, Ramaekers JG, Liechti ME. J Psychopharmacol. 2017 May;31(5):589-598. doi: 10.1177/0269881117699617. https…

Methamphetamine dependence in methadone treatment services in Iran: the first literature review of a new health concern. Alammehrjerdi Z, Ezard N, Dolan K. Asian J Psychiatr. 2018 Jan 6;31:49-55. doi: 10.1016/j.ajp.2018.01.001. Abstract https://…

Opioids and methamphetamine: a tale of two crises The Lancet , Volume 391 , Issue 10122 , 713 http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30319-2/fulltext